Reducing the Risk of Type 2 Diabetes in Nonselected Outpatients With Schizophrenia: A 30-Month Program

Hjorth, Peter; Espensen, Caroline H; Madsen, Nikolaj Juul; Viuff, Anne Grethe; Munk‐Jørgensen, Povl

doi:10.1097/pra.0000000000000278

Cited by 7 publications

(7 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In eight programs, participants took part in only group exercises (21, 22, 24, 28, 30, 31, 33, 34). The analyzed studies show a reduction in BMI and body weight (21, 22, 24, 31), waist circumference (34), and an improvement in physical fitness (28).…”

Section: Resultsmentioning

confidence: 99%

“…Seven programs that implemented walking as a main intervention showed statistically significant changes in the tested parameters (17, 19, 22, 23, 30, 33, 34). In three of them, participants used a pedometer, which supported patients in setting individual goals and helped supervisor to track progress (17, 23, 30).…”

Section: Resultsmentioning

confidence: 99%

“…Sugawara et al applied individual nutritional education provided by a dietitian as the only nonpharmacological intervention for obese people with schizophrenia (20). Four programs applied healthy diet education as an additional intervention (19, 31, 33, 34). One study provided daily healthy meals for participants but did not specify what kind of group activity patients were involved in.…”

Section: Resultsmentioning

confidence: 99%

“…Thirteen authors applied a variety of motivational and educational interventions to increase compliance and hence improve outcomes (17–20, 22, 23, 25, 27, 29–31, 33, 34, 36). Six researchers conducted educational sessions where participants were introduced to healthy behavior, the importance of physical activity, and a healthy diet (17, 19, 20, 30, 33, 34). However, these interventions did not lead to better outcomes compared to those without any educational sessions.…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review

et al. 2019

View full text Add to dashboard Cite

Background: People suffering from schizophrenia are notably vulnerable to cardiometabolic risk factors (CMRF), such as obesity, high blood pressure, hyperglycemia and insulin resistance, high serum triglycerides, and low serum high-density lipoprotein (HDL), which are related to increased mortality and decreased quality of life. The increased risk of “metabolic syndrome” (MS) is related to low physical activity, an unhealthy diet, and side effects of antipsychotic drugs. Nonpharmacological interventions seem to be important in the prevention and therapy of MS. Aim: This paper provides an overview of published studies and a critical analysis of pilot programs involving nonpharmacological measures aimed at prevention and treatment of CMRF in patients with schizophrenia. Material and Method: We searched the PubMed, PsycARTICLES, and Cochrane Library databases to identify clinical trials. We included full-text studies that met the following criteria: age > 18 years, a diagnosis of schizophrenia or schizoaffective disorder, and monitored parameters associated with MS. Results: All 1,555 references were evaluated for inclusion in the review, and 20 met the inclusion criteria. Nonpharmacological interventions led to improvement in physical health and showed a promising potential for implementation in treatment programs dedicated to this particular group of patients. However, a critical analysis revealed limitations, which have implications for the direction of future research. Conclusions: Patients suffering from schizophrenia can benefit from nonpharmacological interventions aimed at counteracting CMRF, improving either metabolic parameters, cardiovascular fitness, or their health perception. Notwithstanding, to achieve long-term effects, future studies should comprise appropriate follow-up procedures.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review

et al. 2019

View full text Add to dashboard Cite

show abstract

“…In schizophrenia, in spite of their knowledge of the acute and long-term risks conferred by diabetes (8), psychiatrists may therefore be more focused on psychiatric symptoms than on comorbid somatic disorders. Other causes of poor diabetes control in schizophrenia may include poor diet and lack of physical activity (27). Individuals with both schizophrenia and type 1 diabetes may represent a particularly vulnerable population at risk for both somatic and psychological issues.…”

Section: Discussionmentioning

confidence: 99%